| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.06 |